Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.1 USD | +4.04% | +48.76% | +175.76% |
04-29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
04-29 | Cullinan Therapeutics, Inc Appoints Mary Kay Fenton as Chief Financial Officer | CI |
Business Summary
Number of employees: 85
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-02-27 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 22-08-14 |
Chief Tech/Sci/R&D Officer | 57 | 17-12-31 | |
Kevin Johnston
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
Chad Messer
IRC | Investor Relations Contact | - | 22-02-28 |
Corinne Savill
PRN | Corporate Officer/Principal | 64 | 17-01-31 |
Stephen Andre
HRO | Human Resources Officer | 62 | 22-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 17-07-31 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 17-07-31 |
Stephen Webster
BRD | Director/Board Member | 63 | 20-08-31 |
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Director/Board Member | 52 | 22-02-27 | |
David Ryan
BRD | Director/Board Member | 57 | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,065,645 | 40,310,790 ( 93.60 %) | 0 | 93.60 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+175.76% | 1.21B | |
+0.67% | 42.4B | |
+46.23% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- CGEM Stock
- Company Cullinan Therapeutics, Inc.